Cargando…

Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer

BACKGROUND: Alterations in protein glycosylation have been related to malignant transformation and tumour progression. We recently showed that low mRNA levels of Golgi alpha-mannosidase MAN1A1 correlate with poor prognosis in breast cancer patients. METHODS: We analysed the role of MAN1A1 on a prote...

Descripción completa

Detalles Bibliográficos
Autores principales:	Legler, Karen, Rosprim, Ricarda, Karius, Tosca, Eylmann, Kathrin, Rossberg, Maila, Wirtz, Ralph M, Müller, Volkmar, Witzel, Isabell, Schmalfeldt, Barbara, Milde-Langosch, Karin, Oliveira-Ferrer, Leticia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2018
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877434/ https://www.ncbi.nlm.nih.gov/pubmed/29381688 http://dx.doi.org/10.1038/bjc.2017.472

Ejemplares similares

Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation
por: Hamester, Fabienne, et al.
Publicado: (2019)

Mechanisms of Tumor-Lymphatic Interactions in Invasive Breast and Prostate Carcinoma
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2020)

Key Role of Hyaluronan Metabolism for the Development of Brain Metastases in Triple-Negative Breast Cancer
por: Hamester, Fabienne, et al.
Publicado: (2022)

Ang-2 is a potential molecular marker for lymphatic metastasis and better response to bevacizumab therapy in ovarian cancer
por: Volk, Annabelle, et al.
Publicado: (2023)

Prognostic Impact of CEACAM1 in Node-Negative Ovarian Cancer Patients
por: Oliveira-Ferrer, Leticia, et al.
Publicado: (2018)

Impact of AKT1 on cell invasion and radiosensitivity in a triple negative breast cancer cell line developing brain metastasis
por: Kempska, Joanna, et al.
Publicado: (2023)

E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
por: Trillsch, Fabian, et al.
Publicado: (2016)

Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
por: Ihnen, M, et al.
Publicado: (2010)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

The role of the desmosomal protein desmocollin 2 in tumour progression in triple negative breast cancer patients
por: Reimer, Francesca, et al.
Publicado: (2023)

Expression and prognostic relevance of activated extracellular-regulated kinases (ERK1/2) in breast cancer
por: Milde-Langosch, K, et al.
Publicado: (2005)

Role of urokinase plasminogen activator and plasminogen activator inhibitor mRNA expression as prognostic factors in molecular subtypes of breast cancer
por: Witzel, Isabell, et al.
Publicado: (2014)

C-Fos expression is a molecular predictor of progression and survival in epithelial ovarian carcinoma
por: Mahner, S, et al.
Publicado: (2008)

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients
por: Ding, Yi, et al.
Publicado: (2022)

Mitotic phosphorylation inhibits the Golgi mannosidase MAN1A1
por: Huang, Shijiao, et al.
Publicado: (2022)

Loss of N-acetylgalactosaminyltransferase 3 in poorly differentiated pancreatic cancer: augmented aggressiveness and aberrant ErbB family glycosylation
por: Chugh, Seema, et al.
Publicado: (2016)

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients
por: Kuerti, Sascha, et al.
Publicado: (2017)

Structure of human endo-α-1,2-mannosidase (MANEA), an antiviral host-glycosylation target
por: Sobala, Łukasz F., et al.
Publicado: (2020)

c-FOS suppresses ovarian cancer progression by changing adhesion
por: Oliveira-Ferrer, L, et al.
Publicado: (2014)

Overexpression and altered glycosylation of MUC1 in malignant mesothelioma
por: Creaney, J, et al.
Publicado: (2008)

Alpha-1,2-Mannosidase and Hence N-Glycosylation Are Required for Regulatory T Cell Migration and Allograft Tolerance in Mice
por: Long, Elaine T., et al.
Publicado: (2010)

Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients
por: Panse, J, et al.
Publicado: (2008)

Mechanisms of Impaired Lung Development and Ciliation in Mannosidase-1-Alpha-2 (Man1a2) Mutants
por: Ningappa, Mylarappa, et al.
Publicado: (2021)

A role for endothelial alpha-mannosidase MAN1C1 in radiation-induced immune cell recruitment
por: Ladaigue, Ségolène, et al.
Publicado: (2022)

Insights into the Steps of Breast Cancer–Brain Metastases Development: Tumor Cell Interactions with the Blood–Brain Barrier
por: Hamester, Fabienne, et al.
Publicado: (2022)

Transcriptome-based variant calling and aberrant mRNA discovery enhance diagnostic efficiency for neuromuscular diseases
por: Hong, Sung Eun, et al.
Publicado: (2022)

Man with Abdominal Distension
por: Canders, Caleb P., et al.
Publicado: (2014)

Aberrant expression of RAB1A in human tongue cancer
por: Shimada, K, et al.
Publicado: (2005)

Old Man with Groin Bruising
por: Bayram, Basak, et al.
Publicado: (2014)

α-1,2-Mannosidase MAN1C1 Inhibits Proliferation and Invasion of Clear Cell Renal Cell Carcinoma
por: Li, Haoming, et al.
Publicado: (2018)

Mannosidases in Mammalian Glycoprotein Processing
por: MOREMEN, KELLEY W., et al.
Publicado: (1988)

Man with Altered Mentation after Trauma
por: Jones, Landon A., et al.
Publicado: (2014)

Aberrant CDKN1A transcriptional response associates with abnormal sensitivity to radiation treatment
por: Badie, C, et al.
Publicado: (2008)

Aberrant methylation of SPARC in human lung cancers
por: Suzuki, M, et al.
Publicado: (2005)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
por: Sørensen, K D, et al.
Publicado: (2013)

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2018)

Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues
por: Lowrie, A G, et al.
Publicado: (2006)

Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer
por: Meng, Xiaodan, et al.
Publicado: (2016)

BORIS, a paralogue of the transcription factor, CTCF, is aberrantly expressed in breast tumours
por: D'Arcy, V, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ach5d16877uhlh06a7r2j79oqq